Geode Capital Management
IDYA icon

Geode Capital Management’s IDEAYA Biosciences IDYA Stock Holding History

Geode Capital Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$97.8M Buy
2,544,717
+119,115
+5% +$4.49M 0.01% 1170
2026
Q2 		$90.4M Sell
2,425,602
-75,122
-3% -$2.3M ﹤0.01% 1274
2026
Q1 		$83.3M Buy
2,500,724
+427,141
+21% +$14.3M 0.01% 1206
2025
Q4 		$71.7M Sell
2,073,583
-76,450
-4% -$2.44M ﹤0.01% 1279
2025
Q3 		$58.5M Buy
2,150,033
+36,869
+2% +$892K ﹤0.01% 1382
2025
Q2 		$44.4M Buy
2,113,164
+33,286
+2% +$639K ﹤0.01% 1491
2025
Q1 		$34.1M Buy
2,079,878
+91,197
+5% +$1.94M ﹤0.01% 1598
2024
Q4 		$51.1M Buy
1,988,681
+43,226
+2% +$1.22M ﹤0.01% 1420
2024
Q3 		$61.6M Buy
1,945,455
+172,838
+10% +$6.55M 0.01% 1300
2024
Q2 		$62.2M Buy
1,772,617
+206,902
+13% +$8.19M 0.01% 1205
2024
Q1 		$68.7M Buy
1,565,715
+214,378
+16% +$9.22M 0.01% 1155
2023
Q4 		$48.1M Buy
1,351,337
+190,232
+16% +$5.68M 0.01% 1360
2023
Q3 		$31.3M Buy
1,161,105
+138,352
+14% +$3.51M ﹤0.01% 1533
2023
Q2 		$24M Buy
1,022,753
+162,819
+19% +$3.35M ﹤0.01% 1727
2023
Q1 		$11.8M Buy
859,934
+54,033
+7% +$900K ﹤0.01% 2146
2022
Q4 		$14.6M Buy
805,901
+179,046
+29% +$3.01M ﹤0.01% 1990
2022
Q3 		$9.35M Buy
626,855
+7,687
+1% +$100K ﹤0.01% 2311
2022
Q2 		$8.54M Buy
619,168
+4,558
+0.7% +$50.7K ﹤0.01% 2365
2022
Q1 		$6.88M Buy
614,610
+47,100
+8% +$694K ﹤0.01% 2603
2021
Q4 		$13.4M Buy
567,510
+36,743
+7% +$854K ﹤0.01% 2236
2021
Q3 		$13.5M Buy
530,767
+144,879
+38% +$3.38M ﹤0.01% 2245
2021
Q2 		$8.1M Buy
385,888
+107,795
+39% +$2.21M ﹤0.01% 2611
2021
Q1 		$6.54M Buy
278,093
+57,324
+26% +$1.11M ﹤0.01% 2647
2020
Q4 		$3.09M Buy
220,769
+52,130
+31% +$706K ﹤0.01% 2852
2020
Q3 		$2.12M Buy
168,639
+54,383
+48% +$673K ﹤0.01% 2850
2020
Q2 		$1.62M Buy
+114,256
New +$900K ﹤0.01% 2954

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $25.3B AUM 15.9% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return
GSK plc
GSK plc London $497M AUM 35.1% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $102B AUM 35.16% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Geode Capital Management's IDYA Position: Q3 2026 in Review

Geode Capital Management increased its IDEAYA Biosciences (IDYA) stake by 4.9% in Q3 2026, buying an estimated $4.49M and bringing the position to 2,544,717 shares worth $97.8M. The position accounts for 0.01% of the portfolio, ranked #1170.

Geode Capital Management first reported a position in IDYA in Q2 2020 and has held it in 26 quarters since. 172 funds tracked by Wall St. Rank hold IDYA as of Q3 2026.

  • Geode Capital Management held 2,544,717 shares of IDEAYA Biosciences worth $97.8M as of Q3 2026.
  • Geode Capital Management bought 119,115 IDEAYA Biosciences shares in Q3 2026, an estimated $4.49M.
  • IDEAYA Biosciences made up 0.01% of Geode Capital Management's portfolio in Q3 2026, its #1170 holding.
  • Geode Capital Management first reported a position in IDEAYA Biosciences in Q2 2020 and has held it in 26 quarters since.
  • 172 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2026.

Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.